Clinical Trial Update: Subcostal TAP Block With Liposomal Bupivacaine Versus Bupivacaine in Donor Nephrectomy Patients: A Prospective Study [Phase 4]

View source ↗

Summary

Phase 4 trial comparing subcostal TAP block with liposomal bupivacaine to standard bupivacaine for donor nephrectomy patients; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Bupivacaine (Bupivacaine)
• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: University of Minnesota | Conditions: Acute Pain | Phase 4 | Status: COMPLETED | Results posted: 2015-11-11